$254.95
+7.86 (+3.18%)
Performance
1D
—
1W
—
1M
—
3M
+1.10%
6M
+44.24%
1Y
+36.26%
YTD
+3.26%
Open$251.04
Previous Close$247.09
Day High$257.65
Day Low$250.91
52W High$298.30
52W Low$122.80
Volume—
Avg Volume226.2K
Market Cap7.54B
P/E Ratio36.82
EPS$6.84
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$263.07
Below
SMA 200
$186.47
Above
RSI (14)
38.4
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
18 analysts
Price Target
-66.0% upside
Current
$254.95
$254.95
Target
$86.77
$86.77
$54.31
$86.77 avg
$114.95
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 389.33M | 971.92M | 894.90M |
| Net Income | 204.94M | 120.52M | 102.54M |
| Profit Margin | 52.6% | 12.4% | 11.5% |
| EBITDA | 167.10M | 242.82M | 232.68M |
| Free Cash Flow | — | 82.52M | 69.44M |
| Rev Growth | — | +7.7% | -5.6% |
| Debt/Equity | — | 0.59 | 0.54 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $207.18 | +0.96% | 166.6 | 397.77B |
| AMGN | Amgen Inc | $353.93 | +1.58% | 24.4 | 188.06B |
| GILD | Gilead Sciences Inc | $138.26 | +0.11% | 20.0 | 170.34B |
| VRTX | Vertex Pharmaceuticals Inc | $454.97 | +1.42% | 29.2 | 115.53B |
| REGN | Regeneron Pharmaceuticals | $749.47 | +1.05% | 17.9 | 80.50B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.70 | +6.70% | 139.7 | 43.84B |